Neuroscientific Biopharmaceuticals Ltd. (MSX) Stock Statistics & Valuation Metrics

Neuroscientific Biopharmaceuticals Ltd. has a market cap or net worth of AUD 19.49M. The enterprise value is AUD 15.52M.

Market Cap

AUD 19.49M

Enterprise Value

AUD 15.52M

Neuroscientific Biopharmaceuticals Ltd. has 389,718,540 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

389,718,540

Owned by Insiders

8.24%

Owned by Institutions

―

Neuroscientific Biopharmaceuticals Ltd.’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -31.58%.

Return on Equity (ROE)

-0.32

Return on Assets (ROA)

-0.31

Return on Invested Capital (ROIC)

-31.58%

Return on Capital Employed (ROCE)

-0.34

Revenue Per Employee

0

Profits Per Employee

-521.46K

Employee Count

9

Asset Turnover

0.00

Inventory Turnover

0.00

The current PE Ratio of Neuroscientific Biopharmaceuticals Ltd. is -3.88. Neuroscientific Biopharmaceuticals Ltd.’s PEG ratio is 0.28.

PE Ratio

-3.88

PS Ratio

0.00

PB Ratio

1.24

Price to FCF

-7.58

Price to Operating Cash Flow

-6.61

PEG Ratio

0.28

In the last 12 months, Neuroscientific Biopharmaceuticals Ltd. had revenue of 0 and earned -4.69M in profits. Earnings per share was -0.01.

Revenue

0

Gross Profit

-1.38M

Operating Income

-5.11M

Pretax Income

-5.10M

Net Income

-4.69M

EBITDA

-3.72M

Earnings Per Share (EPS)

-0.01

In the last 12 months, operating cash flow was -2.78M and capital expenditures 0, giving a free cash flow of -2.78M billion.

Operating Cash Flow

-2.78M

Free Cash Flow

-2.78M

Free Cash Flow per Share

-0.01

Neuroscientific Biopharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-13.20%

Earnings Yield

-25.56%

Beta

0.52

52-Week Price Change

-50.00%

50-Day Moving Average

0.06

200-Day Moving Average

0.08

Relative Strength Index (RSI)

7.24

Average Volume (3m)

165.23K

Neuroscientific Biopharmaceuticals Ltd. upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 27, 2026

Next Earnings Date

Mar 03, 2027

Ex-Dividend Date

―

Neuroscientific Biopharmaceuticals Ltd. as a current ratio of 14.27, with Debt / Equity ratio of 0.59%

Current Ratio

14.27

Quick Ratio

14.27

Debt to Market Cap

0.00

Net Debt to EBITDA

0.68

Interest Coverage Ratio

-1391.44

In the past 12 months, Neuroscientific Biopharmaceuticals Ltd. has paid -402.66K in taxes.

Income Tax

-402.66K

Effective Tax Rate

0.08

Neuroscientific Biopharmaceuticals Ltd. EV to EBITDA ratio is -4.97, with an EV/FCF ratio of -6.66.

EV to Sales

0.00

EV to EBITDA

-4.97

EV to Free Cash Flow

-6.66

EV to Operating Cash Flow

-6.66

Neuroscientific Biopharmaceuticals Ltd. has AUD 4.63M in cash and marketable securities with AUD 87.04K in debt, giving a net cash position of AUD 4.54M billion.

Cash & Marketable Securities

AUD 4.63M

Total Debt

AUD 87.04K

Net Cash

AUD 4.54M

Net Cash Per Share

AUD 0.01

Tangible Book Value Per Share

AUD 0.01

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin

0.00%

Operating Margin

0.00%

Pretax Margin

0.00%

Net Profit Margin

0.00%

EBITDA Margin

0.00%

EBIT Margin

0.00%

The average price target for Neuroscientific Biopharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

―

EPS Growth Forecast

-10.32%

Smart Score

3

AI Score

42